Back to Search
BUSHRA HAQ, MD
MD
Hematology & Oncology Physician
NPI: 1780827857IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD427892(PA)
Education
OTHER
Class of 1998
Research & Publications (9)
Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.
PMID 19245352·Womens Health (Lond)·2009
6-review
Fetal-maternal microchimerism in normal parous females and parous female cancer patients.
PMID 18508187·Exp Hematol·2008
8-other
Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells.
PMID 12732353·Biochem Pharmacol·2003
8-other
Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways.
PMID 12386815·Oncogene·2002
7-preclinical
Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive.
PMID 12102554·Prog Nucleic Acid Res Mol Biol·2002
6-review
Modulation of the herpes simplex virus type-1 UL9 DNA helicase by its cognate single-strand DNA-binding protein, ICP8.
PMID 11112774·J Biol Chem·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 160 HOLLYWOOD DR FL 2
BUTLER, PA 16001 - Phone
- (724) 282-6175
Quick Facts
- NPI
- 1780827857
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 9
Are you this provider?
Claim Your Profile